It has been reported that the inhibition of hypothalamic inflammation leads to a reduction in obesity-induced fasting hyperglycemia derived from abnormal gluconeogenesis and insulin resistance in the liver (Milanski et al., 2012). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.